The present invention relates to methylene urea derivatives of formula I, the use of the compounds of formula I as inhibitors of raf-kinase, the use of the compounds of formula I for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient.
本发明涉及式 I 的亚甲基
脲衍
生物、式 I 化合物作为雷夫激酶
抑制剂的用途、式 I 化合物用于制造药物组合物的用途以及治疗方法,包括将所述药物组合物施用给患者。